SiNtx Technologies Is Maintained at Buy by Ascendiant Capital
SINTX Technologies Analyst Ratings
Maxim Group Maintains Sintx Technologies(SINT.US) With Hold Rating
Maxim Group Maintains Sintx Technologies(SINT.US) With Hold Rating
Maxim Group Maintains Sintx Technologies(SINT.US) With Hold Rating
Sintx Technologies: A Buy Rating With Promising Growth and Market Expansion Opportunities
SINTX Techs Analyst Ratings
Ascendiant Remains a Buy on Sintx Technologies (SINT)
Maxim Group Keeps Their Buy Rating on Sintx Technologies (SINT)
Maxim Group Sticks to Its Buy Rating for Sintx Technologies (SINT)
Sintx Technologies (SINT) Gets a Buy From Ascendiant
Maxim Adjusts Price Target on Sintx Technologies to $6 From $7, Maintains Buy Rating
Maxim Group Maintains Buy on SINTX Technologies, Lowers Price Target to $6
SINTX Technologies Analyst Ratings
Maxim Group Maintains Buy on SINTX Technologies, Lowers Price Target to $7
Maxim Adjusts Price Target on Sintx Technologies to $22 From $35, Maintains Buy Rating
SINTX Technologies Analyst Ratings
Maxim Group Maintains Buy on SINTX Technologies, Lowers Price Target to $22
Analysts Offer Insights on Healthcare Companies: Sintx Technologies (SINT), Motus Gi Holdings (MOTS) and Valneva (VALN)
Maxim Group Sticks to Its Buy Rating for Sintx Technologies (SINT)